Concepedia

Florent Puisset

FP

21

Publications

695

Citations

15

H-Index

2004

Active since

Affiliations

Institut Claudius Regaud(Current)

Inserm

Université Toulouse III - Paul Sabatier

Université Fédérale de Toulouse Midi-Pyrénées

Centre de Recherche en Cancérologie de Toulouse

Florent Puisset is an author at Institut Claudius Regaud specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

2004–2022

21

Publications

21

Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1

Caroline Imbert, Anne Montfort, Marine Fraisse et al. · Nature Communications · 2020 · 117 citations · Full text

Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents

Étienne Chatelut, Mélanie White‐Koning, Ron H.J. Mathijssen et al. · British Journal of Cancer · 2012 · 88 citations · Full text

Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody‐mediated disease

Florent Puisset, Mélanie White‐Koning, Nassim Kamar et al. · British Journal of Clinical Pharmacology · 2013 · 74 citations · Full text

Dexamethasone as a probe for docetaxel clearance

Florent Puisset, Étienne Chatelut, Florence Dalenc et al. · Cancer Chemotherapy and Pharmacology · 2004 · 62 citations

, , +8

The prognostic impact of immune-related adverse events during anti-PD1 treatment in melanoma and non–small-cell lung cancer: a real-life retrospective study

R. Dupont, E. Bérard, Florent Puisset et al. · OncoImmunology · 2019 · 45 citations · Full text

Rows per page

1–5 of 21